FITLIFE BRANDS, INC. (FTLF) FY2024 10-K Annual Report

Filed: Mar 27, 2025
Health Care
Medicinal Chemicals & Botanical ProductsSEC EDGAR

FITLIFE BRANDS, INC. (FTLF) 10-K annual report for fiscal year 2024, filed with SEC EDGAR on Mar 27, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

FITLIFE BRANDS, INC. FY2024 10-K Analysis

Business Overview

  • Core business: provider of proprietary nutritional supplements and wellness products marketed under multiple brands across sports, weight loss, and general nutrition
  • New segment additions: acquired MRC Brands in Feb 2023 and MusclePharm assets in Oct 2023, expanding e-commerce and wholesale distribution
+3 more insights

Management Discussion & Analysis

  • Revenue $64.5M, up 22% YoY from $52.7M; growth driven by acquisitions of MRC & MusclePharm, Legacy FitLife down 10% to $25.4M
  • Gross margin improved to 43.6% vs 40.7% YoY; gross profit increased 31% to $28.1M from $21.4M
+3 more insights

Risk Factors

  • Regulatory risk: FDA dietary supplement regulations with no pre-sale product approval, potential safety or efficacy issues affecting product acceptance and liability
  • Macroeconomic risk: 66% sales dependence on Amazon U.S. Marketplace, changes in Amazon fees or policies could materially impact revenue
+3 more insights

FITLIFE BRANDS, INC. FY2024 Key Financial Metrics
XBRL

Revenue

$64M

+22.3% YoY

Net Income

$9M

+69.6% YoY

Gross Margin

43.6%

+289bp YoY

Operating Margin

20.3%

+602bp YoY

Net Margin

13.9%

+389bp YoY

ROE

24.9%

+528bp YoY

Total Assets

$59M

+5.8% YoY

EPS (Diluted)

$0.91

-15.7% YoY

Operating Cash Flow

$10M

+127.7% YoY

Source: XBRL data from FITLIFE BRANDS, INC. FY2024 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on FITLIFE BRANDS, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.